Skip to content

LPTX

CYPHERPUNK TECHNOLOGIES INC.

NASDAQ · Healthcare · Biotechnology · US

$0.77
−3.15%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue209.0K
Cost of Revenue20.3M427.0K
Gross Profit(20.1M)(427.0K)
Operating Expenses
R&D Expense21.7M25.7M57.2M73.2M45.0M
SG&A Expense15.2M10.9M12.8M13.4M11.8M
General & Admin Expense15.2M10.9M12.8M13.8M11.8M
Selling & Marketing Expense(427.0K)
Other Expenses(23.6M)
Total Operating Expenses13.2M36.5M70.1M86.6M56.8M
Cost and Expenses13.2M36.5M70.1M87.0M56.8M
Operating Income (EBIT)(17.8M)(36.5M)(70.1M)(87.0M)(56.8M)
Non-Operating
Interest Income391.0K916.0K3.1M4.0M925.0K
Interest Expense24.0K24.0K54.0K
Net Interest Income367.0K892.0K3.1M4.0M871.0K
Other Non-Op Income/Expense14.5M46.6M3.1M5.6M2.3M
Non-Operating Income (excl Interest)77.4M(5.6M)(2.4M)
EBT (Pre-Tax Income)1.2M10.1M(67.0M)(81.4M)(54.4M)
Income Tax Expense2.1M5.3M585.0K147.0K
Bottom Line
Net Income(877.0K)4.8M(67.6M)(81.4M)(54.6M)
Earnings from Cont. Ops(23.5M)4.8M(67.6M)(81.4M)(54.6M)
Earnings from Discont. Ops
Bottom Line Net Income(877.0K)4.8M(67.8M)(81.4M)(54.6M)
Per Share
Basic EPS$0.60$0.07($1.81)($3.98)($4.82)
Diluted EPS$0.63$0.07($1.81)($3.98)($4.82)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding176.3M66.1M37.6M20.4M11.3M
Diluted Shares Outstanding176.3M70.7M37.6M20.4M11.3M
Profitability Metrics
EBITDA(95.2M)(36.5M)(70.1M)(81.0M)(54.4M)
D&A5.0K427.0K16.0K
EBIT(95.2M)(36.5M)(70.1M)(81.4M)(54.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026